ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathology.
Marc Shenouda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.